IP to Grant Oversight: Study Calls for Host of Improvements at California Stem Cell Agency
The $3 billion California stem cell agency is laboring under a range of problems that include protection of its intellectual property and management of its nearly 500 grants plus an inadequate ability to track its own performance, a seven-month study said yesterday.
The performance audit by the Moss Adams accounting firm of Seattle, Wash., made 27 recomm…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.